All Topics

Drafted in partnership with the O'Neill Institute for National and Global Health Law at Georgetown University, the purpose of the this model legislation is to: (1) promote the use of all U.S. Food and Drug Administration-approved medication for addiction treatment options in correctional settings; (2) ensure that all incarcerated individuals with a substance use disorder are provided access to medication for addiction treatment while incarcerated, are treated as individual patients, and have individualized treatment plans reflecting their clinical needs and not a one-size-fits-all approach; and (3) ensure that, upon release from a correctional setting, individuals receiving medication for addiction treatment are provided with a connection in the community for continued care, including a prescription for the medication for addiction treatment and the necessary contacts and tools to continue their treatment....

Collateral consequences are legal, regulatory, and policy barriers imposed against an individual arrested for, charged with, or convicted of a criminal offense that often have no connection to the criminal offense. In this document, LAPPA (1) provides a single resource highlighting each jurisdiction’s laws related to collateral consequences; (2) allows for comparison of the laws between jurisdictions; and (3) identifies and highlights any interesting or novel provisions....

The Legislative Analysis and Public Policy Association (LAPPA), in partnership with the Institute for Intergovernmental Relations, developed several resources related to overdose fatality review (OFR), including a complete summary of state OFR laws, a guide on how OFR teams can obtain information from the Indian Health Service, and a guide on how OFR teams can obtain information from the Veterans Health Administration....

Each issue of News Bites will highlight unique news articles from around the United States in the areas of public health and safety, substance use disorders, and the criminal justice system. This newsletter will feature stories that you may have missed but are important to the field....

Case Law Monitor is the bimonthly case law newsletter of the Legislative Analysis and Public Policy Association (LAPPA). Each issue will highlight unique cases from around the United States in the areas of public health and safety, substance use disorders, and the criminal justice system. ...

The purpose of the Model Medicaid Section 1115 Demonstration Waiver Act is to: (1) Require a state department of health and human services to apply for a Medicaid reentry Section 1115 demonstration waiver to allow a state Medicaid program to cover pre-release services for a Medicaid eligible incarcerated individual for up to 90 days prior to the individual’s expected release date and (2) Require a state department of health and human services to conduct comprehensive monitoring and evaluation of the Medicaid reentry demonstration, if the waiver is approved....

The Model Relief from Collateral Consequences of Conviction Act establishes a process for the identification, collection, and publication of state and federal collateral consequences that impact an individual who has been convicted of a crime and establishes a process by which an individual can obtain a certificate of relief from certain collateral consequences before records are eligible to be sealed or expunged....

Each issue of News Bites will highlight unique news articles from around the United States in the areas of public health and safety, substance use disorders, and the criminal justice system. This newsletter will feature stories that you may have missed but are important to the field....

In this fact sheet the Legislative Analysis and Public Policy Association (LAPPA) details the changes to the "primary diagnosis other than OUD" regulation. The fact sheet also covers the federal regulatory scheme for methadone for OUD and explains what led SAMHSA to revise its regulations. ...